Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2019

Dec 18, 2019

30786_dirs_2019-12-17_a2217ea6-cfdc-4cba-9573-60b46d84c1f8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO,BIOB)
CIK: 0000012208
Period of Report: 2019-12-16

Reporting Person: WRIGHT DARA (Executive Vice President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-12-16 Restricted Stock Units $0 A 2511 Acquired Bio-Rad A Common Stock (2511) Direct
2019-12-16 Non-Qualified Stock Option (right to buy) $366.89 A 2511 Acquired 2029-12-16 Bio-Rad A Common Stock (2511) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F2: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F3: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.